Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital

Background: The management of chronic hepatitis B (CHB) infection is complex due to its natural history, which includes fluctuating viral replication and associated hepatic dysfunction. Aims and Objectives: The study was conducted to evaluate quantitative hepatitis B virus (HBV) DNA and hepatitis...

Full description

Saved in:

Bibliographic Details
Main Authors:	Diksha Budhani, Varsha A Singh, Madhurendra Singh Rajput, Varsha Saxena, Pooja Sindwani
Format:	Article
Language:	English
Published:	Manipal College of Medical Sciences, Pokhara 2025-01-01
Series:	Asian Journal of Medical Sciences
Subjects:	hepatitis b surface antigen; chronic hepatitis; hepatitis b virus dna; entecavir; hepatitis b e antigen
Online Access:	https://ajmsjournal.info/index.php/AJMS/article/view/4274
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Experience of entecavir therapy in chronic hepatitis B
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Giuseppe Vittorio Luigi De Socio, et al.
Published: (2011-03-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01)

The Prevalence of Occult Hepatitis B Virus Infection among Hepatitis B Surface Antigen Sero-negative Blood Donors
by: Babandina Muhammad Musa 1, Ocheme Julius Okojokwu 2, Musa Saleh Makeri 3, Khadijat Toyi Musa 4, Amos Dangana 5, Maryam Aladodo 6, Saheed Adekola 7, Nura Muhammad Bunza 8, Zainab Usman-kanfani9, Clara Obiegue 10, Abbas M Babandina11 Musa Abidemi Muhibi 12,
Published: (2025-05-01)

Adherence to entecavir for chronic hepatitis B and correlation with effectiveness
by: Vanessa Romero Díaz-Maroto, et al.
Published: (2015-11-01)

Prospect of emerging treatments for hepatitis B virus functional cure
by: Rex Wan-Hin Hui, et al.
Published: (2025-02-01)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
by: Ying Lu, et al.
Published: (2021-01-01)

Seroprevalence of hepatitis B surface antigen and hepatitis B e antigen among childbearing-age women in Mianyang, China
by: Min Wang, et al.
Published: (2015-07-01)

Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA
by: Hongyu Shen, et al.
Published: (2019-11-01)

Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B
by: Sukjin Hong, et al.
Published: (2025-04-01)

Knowledge and behaviors about hepatitis B prevention and control among carriers of hepatitis B surface antigen
by: LI Siwen, ZHOU Tiantian, ZHANG Chao, ZHANG Dan, HU Weijun
Published: (2025-03-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

Challenges in the Treatment of Acute Fulminant Hepatitis B: Case Report and Literature Review
by: Ali Alawieh, et al.
Published: (2014-08-01)

Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis
by: Yong Wang, et al.
Published: (2025-05-01)

Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria
by: Michael O Iroezindu, et al.
Published: (2013-12-01)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
by: Shao-Juan Wang, et al.
Published: (2021-01-01)

Pregnancy and Hepatitis B Virus Infection
by: Selma TOSUN
Published: (2016-12-01)

Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B
by: Takuya Matsubara, et al.
Published: (2025-01-01)

Genetic variants of hepatitis B virus in patients with chronic hepatitis B
by: E. A. Elpaeva, et al.
Published: (2015-11-01)

National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021
by: Olena Nesterova
Published: (2025-07-01)

Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
by: Liang Wang, et al.
Published: (2025-07-01)

Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels
by: Deliang Huang, et al.
Published: (2023-12-01)

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
by: Ling Ding, et al.
Published: (2025-12-01)

Comparative efficacy and safety of pegylated interferon-alpha monotherapy vs combination therapies with entecavir or tenofovir in chronic hepatitis B patients
by: Huiqing Liang, et al.
Published: (2025-05-01)

The remodeling of B-cell subsets was correlated with the clearance of hepatitis B antigen during pegylated IFN α-2a therapy in CHB patients
by: Lei Tan, et al.
Published: (2025-12-01)

Prevalence of hepatitis B virus infection and associated factors among adults intrafamilial household contacts attending antenatal care clinics in the Central Ethiopian region: from pregnant women index cases
by: Yilma Markos Larebo, et al.
Published: (2025-02-01)

Need of Treatment Modification During Entecavir Therapy in Patients with Chronic Hepatitis B: Long-Term Follow-Up Results for 120 Months
by: Hae Rim Kim, et al.
Published: (2025-01-01)

Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa
by: F. M. Chonco, et al.
Published: (2019-04-01)

Evaluation of the Effectiveness of Hepatitis B Vaccination in Children Aged 1 to 14 Years in Sulaimani City
by: Razhan Sabah Hassan, et al.
Published: (2023-04-01)

Virological and morphological relationships in the phases of the immune control and reactivation in patients with chronic hepatitis B
by: I. A. Gabdrakhmanov, et al.
Published: (2016-02-01)

Treatment of chronic hepatitis B: options, monitoring, special cases and adverse effects
by: Mateusz Litwin Litwin, et al.
Published: (2025-01-01)

Serologic and molecular characteristics of hepatitis B virus infection in vaccinated schizophrenia patients in China
by: Yiying Wang, et al.
Published: (2016-04-01)

CLINICO-LABORATORY CHARACTERISTICS OF HEPATITIS A IN PATIENTS WITH MARKERS OF HEPATITIS B VIRUS
by: E. V. Esaulenko, et al.
Published: (2017-10-01)

Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma
by: Bingyan Hao, et al.
Published: (2025-03-01)

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016-07-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus
by: Tae Un Yang, et al.
Published: (2023-12-01)

Identification of hepatitis B virus mutations in patients with hepatocellular carcinoma
by: A. A. Grishaeva, et al.
Published: (2025-02-01)

Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy
by: Ruyu Liu, et al.
Published: (2023-12-01)